Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
Cancer Immunology Research|February 13, 2026
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-Cell Engineering Against Pancreatic TumorsKhuloud Bajbouj, Zebin Xiao, Leslie Todd, et al.
JCI Insight|August 18, 2017
Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factorsTatiana Akimova, Tianyi Zhang, Dmitri Negorev, et al.
Nature Clinical Practice. Oncology|November 3, 2006
Interferon beta adenoviral gene therapy in a patient with ovarian cancerDaniel H Sterman, Colin T Gillespie, Richard G Carroll, et al.
Nature Medicine|August 20, 2013
Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunityYujie Liu, Liqing Wang, Jarrod Predina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesotheliomaDaniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
Cancer Research|January 25, 2024
Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal TrogocytosisSunil Singhal, Abhishek S Rao, Jason Stadanlick, et al.
Scientific Reports|February 18, 2018
Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanismsDmitri Negorev, Ulf H Beier, Tianyi Zhang, et al.
The Journal of Clinical Investigation|November 11, 2014
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancerEvgeniy B Eruslanov, Pratik S Bhojnagarwala, Jon G Quatromoni, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Cancer Immunology Research|April 30, 2014
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicityLiang-Chuan S Wang, Albert Lo, John Scholler, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Cancer Immunology Research|February 13, 2026
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-Cell Engineering Against Pancreatic TumorsKhuloud Bajbouj, Zebin Xiao, Leslie Todd, et al.
JCI Insight|August 18, 2017
Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factorsTatiana Akimova, Tianyi Zhang, Dmitri Negorev, et al.
Nature Clinical Practice. Oncology|November 3, 2006
Interferon beta adenoviral gene therapy in a patient with ovarian cancerDaniel H Sterman, Colin T Gillespie, Richard G Carroll, et al.
Nature Medicine|August 20, 2013
Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunityYujie Liu, Liqing Wang, Jarrod Predina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesotheliomaDaniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
Cancer Research|January 25, 2024
Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal TrogocytosisSunil Singhal, Abhishek S Rao, Jason Stadanlick, et al.
Scientific Reports|February 18, 2018
Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanismsDmitri Negorev, Ulf H Beier, Tianyi Zhang, et al.
The Journal of Clinical Investigation|November 11, 2014
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancerEvgeniy B Eruslanov, Pratik S Bhojnagarwala, Jon G Quatromoni, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Cancer Immunology Research|April 30, 2014
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicityLiang-Chuan S Wang, Albert Lo, John Scholler, et al.
Pageof 20